SOHM

52 articles about SOHM

• SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers

  4/1/2024

  SOHM, Inc. announces today the collaboration with Coastar Therapeutics, announce their collaboration to advance the field of genome editing using Coastar's red blood cell membrane derived carriers and SOHM's ABBIE (A Binding Based Integrase Enzyme) genome editing technology.

• SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California

  11/21/2023

  SOHM, Inc., a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced its new manufacturing facility at Carlsbad.

• SOHM Collaborates with University of Arizona Center for Innovation to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology

  10/10/2023

  SOHM has entered into development collaboration with the University of Arizona Center for Innovation to propel ABBIE, a non-viral gene-editing kit technology.

• SOHM Inc. Signs LOI to Acquire Stem Cell Disruptive Technology and Patents

  8/1/2023

  SOHM, Inc. announces that the company has signed a letter of intent to acquire stem cell disruptive technology and patents called "ABBIE."

• SOHM, Inc. Signs MOU with London/Asia-Based Fund to Infuse Funds for Various Projects

  10/18/2022

  SOHM, Inc., a generic pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces that it has signed a memorandum of understanding with SRAM & MRAM Group for injections of required funds for the Company's various new pipeline projects.

• SOHM, Inc. Moves a Step Closer in Securing a Definitive Agreement in Previously Announced Proposed Acquisition of Southern California Based Pharmaceutical Company

  8/23/2021

  SOHM, Inc., a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories announced that the Company has finished its due diligence for its previously announced proposed acquisition of a leading Southern California based pharmaceutical company.

• SOHM Receives Semi-Annual Order From Private Label Customer to Boost Anticipated Revenue for 2021

  6/3/2021

  SOHM, Inc., generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced that the Company has received a semi-annual, bi-monthly order for prescription skincare topical products, estimated to have a top-line revenue value of approximately $500k.

• SOHM, Inc. Announce Company Outlook for the Year 2021 – Shareholder Updates

  5/18/2021

  SOHM, Inc. (OTC PINK:SHMN), a generic pharmaceutical, nutraceutical, and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today its outlook for the year 2021. Mr. Baron Night, CEO, announced today that the company management is very happy with the performance of Q1 financials.

• SOHM, Inc., to Focus Growth on Rx-to-OTC Switches with Private Label Products

  5/12/2021

  SOHM, Inc. to take advantage of the FDA converting more prescription Products to the over-the-counter Markets.

• SOHM, Inc., signs a Mutual Letter of Intent for an Acquisition of Southern California based Pharmaceutical Company

  4/27/2021

  SOHM, Inc. (OTC PINK:SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today that the company has signed a Letter of Intent for Acquisition of a leading Southern California based Pharmaceutical company.

• SOHM, Inc. Announces Potential Purchase Orders for a Range of Pharmaceutical Products

  8/2/2018

  SOHM, Inc. is negotiating multiple purchase orders for a range of Pharmaceutical products.

• SOHM, Inc. Files All Quarterly and Annual Financials to Move Current with OTC

  7/26/2018

  SOHM, Inc.’s Annual Financial for year ending 2016, 2017 and first qtr. which is ended on March 31, 2018:

• SOHM, Inc. Reports $180,000 of Total Revenue and a Gross Profit of $95,292 for the First Qtr of 2018

  7/17/2018

  SOHM, Inc. a globally-known generic pharmaceutical manufacturer, release its first Qtr of 2018. 

• SOHM Received Confirmed Orders For OTC Products

  1/6/2015

• SOHM Announces Appointing Of Chair Of Advisory Board Team

  12/4/2014

• SOHM Launches SohMed™ Range Of Branded OTC Medicines In U.S. Market

  11/12/2013

• SOHM Receives an LOI for an Order Worth $1.85 Million to Supply a Range of Generic OTC Products in 2013

  1/18/2013

• SOHM Announces Second Quarter 2012 Financial Results

  10/3/2012

• SOHM Projects 2012 to be Another Record Revenue Year

  2/24/2012

• SOHM Announces Fourth Quarter and Fiscal Year 2011 Operating and Financial Results

  2/8/2012